How much funding does AIM-HI Accelerator Fund (Aim-Hi Accelerator Fund) provide?

Funding amounts vary. Check the grant details for specifics.

When is the deadline for AIM-HI Accelerator Fund (Aim-Hi Accelerator Fund)?

This grant has a rolling deadline or the deadline has not been announced.

AIM-HI Accelerator Fund (Aim-Hi Accelerator Fund)

National Foundation For Cancer Research

Foundation Grants for Cancer Nonprofits Grants for Science Research Grants for Startups

Apply Now

Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

foundation

Overview

AIM-HI Accelerator Fund

Funder: National Foundation for Cancer Research (NFCR)

Purpose: A disruptive funding model designed to accelerate cancer innovations from laboratory bench to patients at their bedside, bridging the "valley of death" between basic research breakthroughs and clinical application.

Funding Model:

Harnesses the power of business leaders and philanthropists in the US and worldwide

Utilizes venture philanthropy and impact investments

Creates an evergreen model of funding innovations and their commercialization

Focuses on measurable outcomes

Focus Areas:

Early-stage cancer innovations waiting for commercialization

Prevention, treatment and care innovations

Genomic-based research applications

Diagnostics and prevention strategies

Next-generation cancer therapies

Problem Addressed:

Many breakthroughs in cancer research remain confined to laboratories and unable to reach clinics

Early-stage areas are extremely risky with high fail rates

Traditional venture capitalists and large pharmaceutical companies unwilling to take these risks

Need for paradigm shift in accelerating cancer innovation to patient benefit

Scope: United States and worldwide

Paradigm:

Moves beyond traditional NFCR focus on basic science to include translational research

Aims to translate laboratory discoveries into FDA-approved therapies

Emphasis on getting innovations into clinics faster

Background: Launched as response to fruition point of past decades' advances in genomic-based research, with many innovations ready for commercialization but lacking adequate funding mechanisms.

Contact:

National Foundation for Cancer Research

Phone: 1-800-321-CURE (2873)

Email: info@nfcr.org

Address: 5515 Security Lane, Suite 1105, Rockville, MD 20852